192 related articles for article (PubMed ID: 28410220)
1. Reprogramming induced by isoliquiritigenin diminishes melanoma cachexia through mTORC2-AKT-GSK3β signaling.
Chen XY; Li DF; Han JC; Wang B; Dong ZP; Yu LN; Pan ZH; Qu CJ; Chen Y; Sun SG; Zheng QS
Oncotarget; 2017 May; 8(21):34565-34575. PubMed ID: 28410220
[TBL] [Abstract][Full Text] [Related]
2. Autophagy participates in isoliquiritigenin-induced melanin degradation in human epidermal keratinocytes through PI3K/AKT/mTOR signaling.
Yang Z; Zeng B; Pan Y; Huang P; Wang C
Biomed Pharmacother; 2018 Jan; 97():248-254. PubMed ID: 29091873
[TBL] [Abstract][Full Text] [Related]
3. Isoliquiritigenin Suppresses Osteosarcoma U2OS Cell Proliferation and Invasion by Regulating the PI3K/Akt Signalling Pathway.
Chen J; Liu C; Yang QQ; Ma RB; Ke Y; Dong F; Wu XE
Chemotherapy; 2018; 63(3):155-161. PubMed ID: 29936511
[TBL] [Abstract][Full Text] [Related]
4. Isoliquiritigenin inhibits proliferation and metastasis of MKN28 gastric cancer cells by suppressing the PI3K/AKT/mTOR signaling pathway.
Zhang XR; Wang SY; Sun W; Wei C
Mol Med Rep; 2018 Sep; 18(3):3429-3436. PubMed ID: 30066879
[TBL] [Abstract][Full Text] [Related]
5. Dual inhibition of the PI3K/AKT/mTOR pathway suppresses the growth of leiomyosarcomas but leads to ERK activation through mTORC2: biological and clinical implications.
Fourneaux B; Chaire V; Lucchesi C; Karanian M; Pineau R; Laroche-Clary A; Italiano A
Oncotarget; 2017 Jan; 8(5):7878-7890. PubMed ID: 28002802
[TBL] [Abstract][Full Text] [Related]
6. The inhibitory effect of Isoliquiritigenin on the proliferation of human arterial smooth muscle cell.
Chen T; Deng S; Lin R
BMC Pharmacol Toxicol; 2017 Jul; 18(1):57. PubMed ID: 28716056
[TBL] [Abstract][Full Text] [Related]
7. Isoliquiritigenin inhibits the proliferation, migration and metastasis of Hep3B cells via suppressing cyclin D1 and PI3K/AKT pathway.
Huang Y; Liu C; Zeng WC; Xu GY; Wu JM; Li ZW; Huang XY; Lin RJ; Shi X
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31840737
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of COX-2, mPGES-1 and CYP4A by isoliquiritigenin blocks the angiogenic Akt signaling in glioma through ceRNA effect of miR-194-5p and lncRNA NEAT1.
Wang C; Chen Y; Wang Y; Liu X; Liu Y; Li Y; Chen H; Fan C; Wu D; Yang J
J Exp Clin Cancer Res; 2019 Aug; 38(1):371. PubMed ID: 31438982
[TBL] [Abstract][Full Text] [Related]
9. Isoliquiritigenin inhibits migration and invasion of prostate cancer cells: possible mediation by decreased JNK/AP-1 signaling.
Kwon GT; Cho HJ; Chung WY; Park KK; Moon A; Park JH
J Nutr Biochem; 2009 Sep; 20(9):663-76. PubMed ID: 18824345
[TBL] [Abstract][Full Text] [Related]
10. Isoliquiritigenin suppresses human melanoma growth by targeting miR-301b/LRIG1 signaling.
Xiang S; Chen H; Luo X; An B; Wu W; Cao S; Ruan S; Wang Z; Weng L; Zhu H; Liu Q
J Exp Clin Cancer Res; 2018 Aug; 37(1):184. PubMed ID: 30081934
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of COX-2 and CYP 4A signaling by isoliquiritigenin inhibits human breast cancer metastasis through preventing anoikis resistance, migration and invasion.
Zheng H; Li Y; Wang Y; Zhao H; Zhang J; Chai H; Tang T; Yue J; Guo AM; Yang J
Toxicol Appl Pharmacol; 2014 Oct; 280(1):10-20. PubMed ID: 25094029
[TBL] [Abstract][Full Text] [Related]
12. LW-213 induces G2/M cell cycle arrest through AKT/GSK3β/β-catenin signaling pathway in human breast cancer cells.
Zhao L; Miao HC; Li WJ; Sun Y; Huang SL; Li ZY; Guo QL
Mol Carcinog; 2016 May; 55(5):778-92. PubMed ID: 25945460
[TBL] [Abstract][Full Text] [Related]
13. Aschantin targeting on the kinase domain of mammalian target of rapamycin suppresses epidermal growth factor-induced neoplastic cell transformation.
Lee CJ; Jang JH; Lee JY; Lee MH; Li Y; Ryu HW; Choi KI; Dong Z; Lee HS; Oh SR; Surh YJ; Cho YY
Carcinogenesis; 2015 Oct; 36(10):1223-34. PubMed ID: 26243309
[TBL] [Abstract][Full Text] [Related]
14. Isoliquiritigenin Inhibits Proliferation and Induces Apoptosis via Alleviating Hypoxia and Reducing Glycolysis in Mouse Melanoma B16F10 Cells.
Wang Y; Ma J; Yan X; Chen X; Si L; Liu Y; Han J; Hao W; Zheng Q
Recent Pat Anticancer Drug Discov; 2016; 11(2):215-27. PubMed ID: 26951491
[TBL] [Abstract][Full Text] [Related]
15. Isoliquiritigenin impairs insulin signaling and adipocyte differentiation through the inhibition of protein-tyrosine phosphatase 1B oxidation in 3T3-L1 preadipocytes.
Park SJ; Choe YG; Kim JH; Chang KT; Lee HS; Lee DS
Food Chem Toxicol; 2016 Jul; 93():5-12. PubMed ID: 27117918
[TBL] [Abstract][Full Text] [Related]
16. Isoliquiritigenin inhibits the proliferation, apoptosis and migration of osteosarcoma cells.
Li C; Zhou X; Sun C; Liu X; Shi X; Wu S
Oncol Rep; 2019 Apr; 41(4):2502-2510. PubMed ID: 30720124
[TBL] [Abstract][Full Text] [Related]
17. PI3K/Akt promotes feedforward mTORC2 activation through IKKα.
Dan HC; Antonia RJ; Baldwin AS
Oncotarget; 2016 Apr; 7(16):21064-75. PubMed ID: 27027448
[TBL] [Abstract][Full Text] [Related]
18. Discovery of novel isoliquiritigenin analogue ISL-17 as a potential anti-gastric cancer agent.
Huang F; Wang J; Xu Y; Zhang Y; Xu N; Yin L
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32515470
[TBL] [Abstract][Full Text] [Related]
19. Isoliquiritigenin Induces Mitochondrial Dysfunction and Apoptosis by Inhibiting mitoNEET in a Reactive Oxygen Species-Dependent Manner in A375 Human Melanoma Cells.
Chen XY; Ren HH; Wang D; Chen Y; Qu CJ; Pan ZH; Liu XN; Hao WJ; Xu WJ; Wang KJ; Li DF; Zheng QS
Oxid Med Cell Longev; 2019; 2019():9817576. PubMed ID: 30805086
[TBL] [Abstract][Full Text] [Related]
20. Anti-proliferative and cytotoxic activities of the flavonoid isoliquiritigenin in the human neuroblastoma cell line SH-SY5Y.
Escobar SJM; Fong GM; Winnischofer SMB; Simone M; Munoz L; Dennis JM; Rocha MEM; Witting PK
Chem Biol Interact; 2019 Feb; 299():77-87. PubMed ID: 30502331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
